Orionis Biosciences
Azza A. Gadir, PhD has extensive work experience in the field of biosciences. Azza currently serves as a Portfolio Manager at Orionis Biosciences since March 2021. Prior to this, they were involved with Seed Health, where they held the positions of Scientific Advisor and Director of R&D from November 2018 to March 2021.
Before joining Seed Health, Azza served as a Postdoctoral Research Fellow at Boston Children's Hospital - Harvard Medical School from August 2011 to October 2018. Azza completed their PhD in Immunology at University College London, where they began their research career in September 2007 and successfully finished their studies in July 2011.
Azza A. Gadir, PhD began their education at King's College London in 2003, where they earned a Bachelor of Science degree in Biochemistry and Immunology in 2006. Azza then pursued further education at the London School of Hygiene and Tropical Medicine, University of London from 2006 to 2007, where they obtained a Master of Science degree in Immunology of Infectious Diseases.
This person is not in any teams
This person is not in any offices
Orionis Biosciences
1 followers
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.